prescription drugs

Senate Democrats spent the weekend advancing what they call a historic piece of legislation, but it's still a much smaller version of what they — and President Biden — originally called for.

The Arizona senator said she will move forward with the Inflation Reduction Act after Democrats reached an agreement to remove a carried interest tax provision.

Two Washington Post journalists say pharmaceutical companies collaborated with each other — and with lawyers and lobbyists — to create laws to protect the industry. Their new book is American Cartel.

Even the savviest Medicare drug plan shoppers can get a shock when they fill prescriptions: That great deal on medications in fall is no bargain after prices go up as much as 8% by winter.

Oklahoma was one of the first states to successfully sue drugmakers for their role in the opioid epidemic, but almost none of that money has been spent so far. A bill moving through the legislature could change that.

The Sacklers, who own Purdue Pharma, maker of Oxycontin, have maintained they did nothing wrong. People who lost loved ones and years of their lives to opioid addiction believe otherwise.

The deal, hashed out over weeks of intense negotiations, raises the amount paid by the Sacklers by more than $1 billion. In exchange, the family members win immunity from civil opioid lawsuits.

Companies at the center of the deadly prescription opioid epidemic are close to deals that would cap their liability while funding drug treatment and recovery programs.

The lawsuit brought by more than 100 tribal nations will benefit all 574 federally recognized tribes.

Johnson & Johnson, AmerisourceBergen, McKesson and Cardinal Health will pay $590 million to Native American tribes under a proposed settlement for the companies' role in the opioid crisis.